KYNB — KYNTRA BIO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $5.3M | -36.1% | -$17.3M | -108.0% | — | — | 8.9% | — | — | — | — |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -3.91 | — | -2.89 | -4.80 | 3 | — |
| Mar 2027 | -2.87 | — | -2.87 | -2.87 | 1 | — |
| Jun 2027 | -3.08 | — | -3.08 | -3.08 | 1 | — |
| Sep 2027 | -3.05 | — | -3.05 | -3.05 | 1 | — |
| Dec 2027 | -3.02 | — | -3.02 | -3.02 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -16.04 | — | -14.28 | -17.61 | 3 | — |
| Dec 2027 | -12.58 | — | -9.27 | -16.45 | 3 | — |
| Dec 2028 | -13.51 | — | -9.21 | -19.54 | 3 | — |
| Dec 2029 | -24.12 | — | -24.12 | -24.12 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-18 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 34 SEC-registered investment managers reported holding KYNB (KYNTRA BIO INC) in their latest 13F filings, with a combined reported value of $6.96M across 1.05M shares. That is +0.2% by share count (+1.49K shares) versus the previous quarter, while reported value moved -11.8%. Ownership is concentrated: the five largest holders account for 74.1% of reported value and the top ten for 88.8%.
Compared with the prior quarter, 8 opened new positions, 4 added to existing stakes, 6 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of KYNTRA BIO INC (KYNB) include ARMISTICE CAPITAL, LLC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, ranked by reported 13F value among the 48 institutional holders on this page.
KYNB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 34 | 1.05M | $6.96M | +0.2% |
| Q2 2026 | 27 | 1.01M | $7.60M | -2.6% |
| Q1 2026 | 32 | 1.02M | $6.88M | +4.8% |
| Q4 2025 | 31 | 1.06M | $9.32M | -0.3% |
| Q3 2025 | 29 | 1.06M | $12.96M | +5.7% |
| Q2 2025 | 26 | 960.86K | $5.09M | — |
Over the 6 quarters shown, institutional share counts increased 9% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q3 2025 (+5.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $2.66M | 0.04% | Hold | |
| 159.95K | $1.06M | 0.00% | Hold | |
| 89.40K | $594.51K | 0.00% | Hold | |
| 84.33K | $560.79K | 0.00% | Hold | |
| 41.39K | $275.30K | 0.00% | Reduce | |
| 39.75K | $264.31K | 0.00% | Hold | |
| 35.28K | $234.62K | 0.00% | Add | |
| 31.32K | $208.26K | 0.00% | Reduce | |
| 24.14K | $160.56K | 0.00% | New | |
| 24.11K | $160.30K | 0.00% | Hold | |
| 23.67K | $157.42K | 0.00% | New | |
| 22.57K | $150.06K | 0.09% | Hold | |
| 20.28K | $134.89K | 0.00% | Hold | |
| 20.16K | $134.00K | 0.01% | Add | |
| 14.34K | $95.37K | 0.01% | New | |
| 8.77K | $58.31K | 0.00% | Add | |
| 2.13K | $14.00K | 0.00% | Add | |
| 1.42K | $9.47K | 0.00% | Hold | |
| 1.12K | $7.42K | 0.00% | Reduce | |
| 704 | $4.68K | 0.00% | Hold | |
| 567 | $3.77K | 0.00% | Reduce | |
| 487 | $3.24K | 0.00% | Hold | |
| 200 | $1.33K | 0.00% | Hold | |
| 193 | $1.28K | 0.00% | Hold | |
| 160 | $1.06K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $3.02M | 0.04% | Hold | |
| 159.95K | $1.21M | 0.00% | Add | |
| 89.40K | $674.97K | 0.00% | Hold | |
| 84.33K | $636.69K | 0.00% | Hold | |
| 43.22K | $326.38K | 0.00% | New | |
| 43.22K | $326.38K | 0.00% | Reduce | |
| 39.75K | $300.08K | 0.00% | Hold | |
| 39.51K | $298.31K | 0.00% | Reduce | |
| 27.08K | $204.46K | 0.00% | Reduce | |
| 24.11K | $181.99K | 0.00% | Add | |
| 22.57K | $170.37K | 0.08% | Hold | |
| 15.70K | $119.00K | 0.01% | New | |
| 7.86K | $59.32K | 0.00% | Reduce | |
| 4.41K | $33.27K | 0.00% | Add | |
| 1.42K | $10.75K | 0.00% | Hold | |
| 1.11K | $8.40K | 0.00% | Add | |
| 704 | $5.32K | 0.00% | Hold | |
| 487 | $3.68K | 0.00% | Hold | |
| 200 | $1.51K | 0.00% | Hold | |
| 193 | $1.45K | 0.00% | Hold | |
| 182 | $1.37K | 0.00% | Add | |
| 160 | $1.21K | 0.00% | Hold | |
| 152 | $1.15K | 0.00% | Hold | |
| 138 | $1.00K | 0.00% | Add | |
| 46 | $347 | 0.00% | Reduce |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $2.71M | 0.05% | Hold | |
| 156.61K | $1.06M | 0.00% | New | |
| 89.40K | $606.13K | 0.00% | Add | |
| 84.33K | $571.76K | 0.00% | Hold | |
| 49.51K | $335.69K | 0.00% | Reduce | |
| 46.00K | $311.94K | 0.00% | Add | |
| 39.74K | $269.46K | 0.00% | Hold | |
| 27.59K | $187.07K | 0.00% | Add | |
| 27.48K | $186.32K | 0.00% | Reduce | |
| 23.94K | $162.33K | 0.00% | New | |
| 22.57K | $153.00K | 0.09% | New | |
| 20.28K | $137.53K | 0.00% | Hold | |
| 12.23K | $82.91K | 0.00% | Reduce | |
| 10.47K | $70.98K | 0.01% | Hold | |
| 1.42K | $9.65K | 0.00% | New | |
| 1.00K | $6.78K | 0.00% | Reduce | |
| 704 | $4.77K | 0.00% | New | |
| 488 | $3.31K | 0.00% | Reduce | |
| 332 | $2.25K | 0.00% | Add | |
| 200 | $1.36K | 0.00% | New | |
| 193 | $1.30K | 0.00% | New | |
| 180 | $1.22K | 0.00% | Add | |
| 160 | $1.08K | 0.00% | Hold | |
| 152 | $1.03K | 0.00% | Hold | |
| 137 | $1.00K | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 400.00K | $3.51M | 0.04% | Add | |
| 181.97K | $1.60M | 0.00% | Reduce | |
| 84.69K | $743.58K | 0.00% | Hold | |
| 61.21K | $537.43K | 0.00% | Add | |
| 47.10K | $413.54K | 0.00% | Hold | |
| 43.70K | $383.81K | 0.00% | Hold | |
| 39.75K | $348.97K | 0.00% | Hold | |
| 32.50K | $285.37K | 0.00% | Reduce | |
| 31.68K | $278.16K | 0.00% | Add | |
| 22.81K | $200.26K | 0.00% | New | |
| 20.28K | $178.09K | 0.00% | Hold | |
| 16.76K | $147.12K | 0.00% | Reduce | |
| 12.85K | $112.84K | 0.00% | New | |
| 12.50K | $109.72K | 0.00% | New | |
| 12.19K | $106.99K | 0.00% | Reduce | |
| 10.47K | $91.92K | 0.01% | New | |
| 10.01K | $87.91K | 0.00% | New | |
| 9.43K | $82.81K | 0.00% | Add | |
| 5.92K | $52.01K | 0.00% | Add | |
| 4.59K | $40.28K | 0.00% | Reduce | |
| 595 | $5.22K | 0.00% | Hold | |
| 216 | $1.90K | 0.00% | Reduce | |
| 160 | $1.41K | 0.00% | Hold | |
| 152 | $1.33K | 0.00% | Hold | |
| 138 | $1.00K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 378.00K | $4.63M | 0.07% | Add | |
| 184.24K | $2.26M | 0.00% | Add | |
| 84.75K | $1.04M | 0.00% | Hold | |
| 72.45K | $887.50K | 0.00% | Hold | |
| 58.88K | $721.27K | 0.00% | Reduce | |
| 47.10K | $576.98K | 0.00% | Reduce | |
| 43.68K | $535.23K | 0.00% | Reduce | |
| 40.22K | $492.67K | 0.00% | Add | |
| 39.75K | $486.89K | 0.00% | Hold | |
| 29.28K | $358.69K | 0.00% | Add | |
| 23.52K | $288.08K | 0.00% | New | |
| 20.28K | $248.48K | 0.00% | Add | |
| 16.37K | $200.53K | 0.00% | New | |
| 8.67K | $106.17K | 0.00% | Reduce | |
| 4.63K | $56.69K | 0.00% | Reduce | |
| 2.17K | $26.56K | 0.00% | New | |
| 1.55K | $18.94K | 0.00% | Reduce | |
| 642 | $7.86K | 0.00% | Hold | |
| 595 | $7.29K | 0.00% | Add | |
| 288 | $3.53K | 0.00% | Reduce | |
| 193 | $2.32K | 0.00% | Hold | |
| 137 | $2.00K | 0.00% | Hold | |
| 160 | $1.96K | 0.00% | Hold | |
| 152 | $1.86K | 0.00% | Hold | |
| 49 | $600 | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 336.00K | $1.78M | 0.03% | New | |
| 178.04K | $943.61K | 0.00% | New | |
| 89.70K | $475.39K | 0.00% | New | |
| 84.75K | $449.18K | 0.00% | New | |
| 72.30K | $383.19K | 0.00% | New | |
| 55.50K | $294.15K | 0.00% | New | |
| 44.04K | $233.44K | 0.00% | New | |
| 39.75K | $210.65K | 0.00% | New | |
| 14.11K | $74.79K | 0.00% | New | |
| 13.72K | $72.71K | 0.00% | New | |
| 11.18K | $59.26K | 0.00% | New | |
| 10.29K | $54.52K | 0.00% | New | |
| 7.21K | $38.21K | 0.00% | New | |
| 1.66K | $8.80K | 0.00% | New | |
| 793 | $4.20K | 0.00% | New | |
| 642 | $3.40K | 0.00% | New | |
| 443 | $2.35K | 0.00% | New | |
| 193 | $1.01K | 0.00% | New | |
| 137 | $1.00K | 0.00% | New | |
| 160 | $848 | 0.00% | New | |
| 152 | $806 | 0.00% | New | |
| 48 | $254 | 0.00% | New | |
| 40 | $212 | 0.00% | New | |
| 12 | $64 | 0.00% | New | |
| 1 | $5 | 0.00% | New |
New Positions (Q3 2026)
- Citadel Advisors 24.14K sh · $160.56K
- OPPENHEIMER & CO INC 23.67K sh · $157.42K
- ADAR1 Capital Management, LLC 14.34K sh · $95.37K
- Nova Financial LLC 160 sh · $1.06K
- Fidelity Management & Research (FMR) 8 sh · $53
- Cassaday & Co Wealth Management LLC 4 sh · $27
- CFG Wealth Management Services, Inc. 3 sh · $20
- BARCLAYS PLC 3 sh · $20
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 43.22K sh · $326.38K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 400.00K | 400.00K | 400.00K | 400.00K | 378.00K | 336.00K |
| VANGUARD CAPITAL MANAGEMENT LLC | 159.95K | 159.95K | 156.61K | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 89.40K | 89.40K | 89.40K | 47.10K | 47.10K | 55.50K |
| BlackRock Inc | 84.33K | 84.33K | 84.33K | 84.69K | 84.75K | 84.75K |
| Geode Capital Management | 41.39K | 43.22K | 46.00K | 43.70K | 43.68K | 44.04K |
| HighTower Advisors, LLC | 39.75K | 39.75K | 39.74K | 39.75K | 39.75K | 39.75K |
| Renaissance Technologies | 35.28K | 27.08K | 27.48K | 31.68K | 29.28K | 11.18K |
| Two Sigma Investments | 31.32K | 39.51K | 49.51K | 61.21K | 40.22K | 14.11K |
| Citadel Advisors | 24.14K | — | — | 16.76K | 23.52K | — |
| VANGUARD FIDUCIARY TRUST CO | 24.11K | 24.11K | 23.94K | — | — | — |
| OPPENHEIMER & CO INC | 23.67K | — | — | — | — | — |
| Birchview Capital, LP | 22.57K | 22.57K | 22.57K | — | — | — |
| STATE STREET CORP | 20.28K | — | 20.28K | 20.28K | 20.28K | 13.72K |
| GSA CAPITAL PARTNERS LLP | 20.16K | 15.70K | — | — | — | — |
| ADAR1 Capital Management, LLC | 14.34K | — | 10.47K | 10.47K | — | — |
| UBS Group AG | 8.77K | 7.86K | 27.59K | 9.43K | 8.67K | 10.29K |
| ROYAL BANK OF CANADA | 2.13K | 138 | 137 | 138 | 137 | 137 |
| Vanguard Global Advisers, LLC | 1.42K | 1.42K | 1.42K | — | — | — |
| GROUP ONE TRADING LLC | 1.12K | 4.41K | 1.00K | 4.59K | 4.63K | 7.21K |
| Axiom Investment Management LLC | 704 | 704 | 704 | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold KYNB?
As of 2026-Q3, 34 institutional funds reported holding KYNB (KYNTRA BIO INC) in SEC 13F filings, with a combined reported value of $6.96M.
How many shares of KYNB do institutions own?
13F filers reported 1.05M shares of KYNB, worth $6.96M in aggregate at the end of 2026-Q3.
Is institutional ownership of KYNB rising or falling?
Share counts moved +0.2% versus the prior quarter — accumulation.
Who are the top institutional holders of KYNB?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, PRIMECAP MANAGEMENT CO/CA/, SUSQUEHANNA INTERNATIONAL GROUP, LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of KYNTRA BIO INC?
The major shareholders of KYNTRA BIO INC (KYNB) by reported 13F value are ARMISTICE CAPITAL, LLC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, PRIMECAP MANAGEMENT CO/CA/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, among 48 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.